StockData
Agenus Inc logo

Agenus Inc (AGEN) stock

AGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30
$6.40+0.19 (+3.06%)

Close on Nov 18, 2026Market cap $288.13MP/E –Yield –

Agenus operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Agenus's operating cash flow for the twelve months ending Jun 30, 2026 was -$98.50M. For fiscal 2025 it was -$77.20M. The highest annual figure on record is $10.15M in fiscal 2021.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$77.20M–
FY2024Dec 31, 2024-$158.32M–
FY2023Dec 31, 2023-$224.20M–
FY2022Dec 31, 2022-$175.37M-1828.7%
FY2021Dec 31, 2021$10.15M–
FY2020Dec 31, 2020-$139.10M–
FY2019Dec 31, 2019-$18.68M–
FY2018Dec 31, 2018-$131.10M–
FY2017Dec 31, 2017-$94.23M–
FY2016Dec 31, 2016-$79.96M–
FY2015Dec 31, 2015-$47.18M–
FY2014Dec 31, 2014-$38.23M–
FY2013Dec 31, 2013-$19.53M-2029.0%
FY2012Dec 31, 2012$1.01M–
FY2011Dec 31, 2011-$16.25M–
FY2010Dec 31, 2010-$14.76M–
FY2009Dec 31, 2009-$24.19M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$31.20M–
Q1 FY2026Mar 31, 2026-$35.95M–
Q4 FY2025Dec 31, 2025-$16.62M–
Q3 FY2025Sep 30, 2025-$14.74M–
Q2 FY2025Jun 30, 2025-$20.22M–
Q1 FY2025Mar 31, 2025-$25.62M–
Q4 FY2024Dec 31, 2024-$28.65M–
Q3 FY2024Sep 30, 2024-$53.29M–
Q2 FY2024Jun 30, 2024-$38.18M–
Q1 FY2024Mar 31, 2024-$38.19M–
Q4 FY2023Dec 31, 2023-$40.40M–
Q3 FY2023Sep 30, 2023-$65.23M–
Q2 FY2023Jun 30, 2023-$60.04M–
Q1 FY2023Mar 31, 2023-$58.53M–
Q4 FY2022Dec 31, 2022-$47.34M–
Q3 FY2022Sep 30, 2022-$32.19M-124.5%
Q2 FY2022Jun 30, 2022-$43.45M–
Q1 FY2022Mar 31, 2022-$52.39M–
Q4 FY2021Dec 31, 2021-$22.93M–
Q3 FY2021Sep 30, 2021$131.37M–
Q2 FY2021Jun 30, 2021-$55.56M–
Q1 FY2021Mar 31, 2021-$42.74M–
Q4 FY2020Dec 31, 2020-$35.59M–
Q3 FY2020Sep 30, 2020-$31.63M–
Q2 FY2020Jun 30, 2020-$37.38M-191.4%
Q1 FY2020Mar 31, 2020-$34.51M-145.1%
Q4 FY2019Dec 31, 2019-$31.78M–
Q3 FY2019Sep 30, 2019-$27.79M–
Q2 FY2019Jun 30, 2019$40.90M–
Q1 FY2019Mar 31, 2019$76.59M–
Q4 FY2018Dec 31, 2018-$35.80M–
Q3 FY2018Sep 30, 2018-$24.60M–
Q2 FY2018Jun 30, 2018-$30.50M–
Q1 FY2018Mar 31, 2018-$40.25M–
Q4 FY2017Dec 31, 2017-$25.80M-261.3%
Q3 FY2017Sep 30, 2017-$26.20M-210.1%
Q2 FY2017Jun 30, 2017-$27.40M–
Q1 FY2017Mar 31, 2017-$14.83M–
Q4 FY2016Dec 31, 2016$16.00M–
Q3 FY2016Sep 30, 2016$23.80M–

More Agenus figures

See a number that looks wrong?